The Patent Page

Chronic Kidney Disease

• Method and kit for reducing the symptoms of peripheral vascular disease
  
• Method of evaluating a subject for risk or predisposition of reduced renal function over time
  
• Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure
  
• Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
  
• Cyclohexenone compounds from Antrodia camphorata to treat autoimmune diseases
  
• Method of treating Crohn's Disease using sargramostim
  
• Fc.gamma.RIIa transgenic animal model for autoimmune disease
  
• Prophylactic and therapeutic immunization against protozoan infection and disease
  
• Polypeptide useful for a non-invasive test for inflammatory bowel disease
  
• Method and kit for reducing the symptoms of peripheral vascular disease
  
• Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an ischemia phase
  
• Compositions and methods for the prevention and treatment of cardiovascular diseases
  
• Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
  
• Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases
  
• Fc.gamma.RIIa transgenic animal model for autoimmune disease
  

Dialysis

• Cyclic derivatives as modulators of chemokine receptor activity
  
• Method and apparatus for preventing dialysis graft intimal hyperplasia
  
• Antibodies to a chemokine expressed in inflamed adenoid
  
• Method and apparatus for preventing dialysis graft intimal hyperplasia
  
• Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane
  
• Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
  
• Chemokine PANEC-2 polypeptides and compositions and methods related thereto
  
• Methods of treating hemophilia or von willebrand disease with p-selectin
  
• Antibodies to a chemokine expressed in inflamed adenoid
  
• Method and device for filtering body fluid
  

Cardiovascular

• Identifying susceptibility to cardiac hypertrophy
  
• Method of predicting genetic risk for hypertension
  
• Nitric oxide-releasing molecules
  
• Thrombopoietin protein variants
  
• Methods and compositions for the repair and/or regeneration of damaged myocardium
  
• Preparation of compositions to alleviate inflammation and oxidative stress in a mammal
  
• Compositions for alleviating inflammation and oxidative stress in a mammal
  
• Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an ischemia phase
  
• Automatic detection and quantification of coronary and aortic calcium
  
• Compositions and methods for the prevention and treatment of cardiovascular diseases
  

Hypertension

• Method of predicting genetic risk for hypertension
  
• Pharmaceutical composition for the prevention or treatment of cerebral oedemas
  
• Failsafe satellite pacemaker system
  
• Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure
  
• RBP4 in insulin sensitivity/resistance, diabetes, and obesity
  
• Topical delivery of trace metals for skin care
  
• Selection of intracellular immunoglobulins
  
• External plaster containing 4-biphenylacetic acid
  
• Substituted 3-carbonyl-1h-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
  
• Method of spray freeze drying proteins for pharmaceutical administration
  

Diabetes

• Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
  
• RBP4 in insulin sensitivity/resistance, diabetes, and obesity
  
• Antibodies against insulin-like growth factor I receptor and uses thereof
  
• Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
  
• Insulin-like growth factor agonist molecules
  

Inflammation

• Somatostatin-dopamine chimeric analogs
  
• Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
  
• Cytokine inhibitors
  
• Cytokine zalpha11 ligand fusion proteins
  
• Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
  
• Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
  
• Preparation of compositions to alleviate inflammation and oxidative stress in a mammal
  
• Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
  
• Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
  
• Human cytokine receptor
  
• Compositions for alleviating inflammation and oxidative stress in a mammal
  
• Polypeptide useful for a non-invasive test for inflammatory bowel disease
  
• Promyostatin peptides and methods of using same
  
• WNT-regulated cytokine-like polypeptide and nucleic acids encoding same
  
• Statin derivatives
  

Vascular Disease

• Method and kit for reducing the symptoms of peripheral vascular disease
  
• Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure
  
• Method and apparatus for preventing dialysis graft intimal hyperplasia
  
• Combined cancer treatment methods using selected antibodies to aminophospholipids
  
• Methods and compositions for selective modulation of vascularization
  
• Selected antibody compositions for binding to aminophospholipids
  
• Method and kit for reducing the symptoms of peripheral vascular disease
  
• Method for differentiating primate embryonic stem cell into vascular cell
  
• Diagnosing peripheral vascular disease by monitoring oxygen saturation changes during an ischemia phase
  
• Method to induce neovascular formation and tissue regeneration
  
• Drug-eluting intravascular prostheses and methods of use
  
• Compositions and methods for the prevention and treatment of cardiovascular diseases
  
• Method and apparatus for preventing dialysis graft intimal hyperplasia
  

Vascular Calcification

• Heterocyclic derivatives for modulation of calcium channels
  
• Automatic detection and quantification of coronary and aortic calcium
  
• Fetuin-MGP-mineral complex in serum assayed to determine calcification risk
  
• Fetuin-MGP-mineral complex in serum assayed to determine calcification risk
  

Medicine

• Substituted biphenyl GPR40 modulators
  
• Use of thianecarboxamides as dgat inhibitors
  
• Cytokine inhibitors
  
• Substituted biphenyl GPR40 modulators
  
• Albumin fusion proteins
  
• Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
  
• Failsafe satellite pacemaker system
  
• Heregulin variants
  
• Methods and compositions for regenerating tissue
  
• Soft tissue repair and regeneration using postpartum-derived cells
  
• hGC-1, a gene encoding a member of the olfactomedin-related protein family
  
• Ion binding polymers and uses thereof
  
• Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of glomerulosclerosis and renal failure
  
• Caspase inhibitors and uses thereof
  
• Method and apparatus for preventing dialysis graft intimal hyperplasia
  
• Antibodies that specifically bind to GMAD
  
• Anti-tango294 antibodies and uses thereof
  
• Benzimidazole derivative and use as a II receptor antagonist
  
• Transferrin receptor antibodies
  
• Non-hygroscopic L-carnitine salts
  
• Nanoparticle composite-coated glass microspheres for use in bioassays
  
• Activation and expansion of T cells
  
• Thermostable ribonuclease H obtained from Archeoglobus profundus
  
• Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides spp
  
• Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
  
• Apparatus for fluid purification and methods of manufacture and use thereof
  
• Computerized system and method for processing a number of attachments associated with a patient
  
• Self contained wound dressing with micropump
  
• Autophilic antibodies
  
• Method of use of carboxylated polysaccharides topically on the eyeball
  
• Multiplex spatial profiling of gene expression
  
• Vitamin D receptor modulators
  
• Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
  
• Cyclohexenone compounds from Antrodia camphorata to treat autoimmune diseases
  
• Phenyl-furan compounds as vitamin D receptor modulators
  
• Pyridyl-substituted porphyrin compounds and methods of use thereof
  
• Preparation of compositions to alleviate inflammation and oxidative stress in a mammal
  
• Method of delivering therapeutic agents to site of tissue injury
  
• Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
  
• Benzamide inhibitors of factor Xa
  
• Dithiocarbamate antiviral agents and methods of using same
  
• External plaster containing 4-biphenylacetic acid
  
• Piperidines
  
• Methods and compositions for diagnosing and monitoring transplant rejection
  
• Polynucleotide encoding IL-1 zeta, TDZ.1 isoform polypeptide
  
• Heteroaryl carboxamide compounds
  
• Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
  
• Multi-domain amphipathic helical peptides and methods of their use
  
• Alpha-2 adrenergic receptor polymorphisms
  
• Application of a therapeutic substance to a tissue location using an expandable medical device
  
• Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
  
• Pyrazolo[4,3-D]pyrimidines
  
• Method for enhanced parenteral nutrition
  
• Substituted 3-carbonyl-1h-indol-1yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
  
• Modifying pirfenidone treatment for patients with atypical liver function
  
• Biaryl piperazinyl-pyridine analogues
  
• Stable tablet formulation
  
• Multiple lumen heat exchange catheters
  
• Traction balloon
  
• Orthovoltage radiotherapy
  
• Statin derivatives
  
• Benzamidazoles, compositions containing such compounds and methods of use
  
• Methods for treating cognitive impairments or dementia
  
• Substituted imidazo(1,2-A)pyrimidines and imidazo(1,2-A) pyridines as cannabinoid receptor ligands
  
• Pyrrolo[1,2-a]quinoxalin-5-(4H)-yl)sulfonyls and carbonyls and their use as estrogenic agents
  
• Method to induce neovascular formation and tissue regeneration
  
• Heregulin variants
  
• Breeding and milking cows for milk free of .beta.-casein A.sup.1
  
• Jucara and Acai fruit-based dietary supplements
  
• Drug-eluting intravascular prostheses and methods of use
  
• Emboli filtration system and methods of use
  
• Automatic detection and quantification of coronary and aortic calcium
  
• Methods and compositions for vitamin K epoxide reductase
  
• Systems and methods of non-standard spiral cone-beam computed tomograpy (CT)
  
• Methods for detecting activity of clottings factors
  
• Growth arrest homebox gene
  
• Growth arrest homeobox gene
  
• Fetuin-MGP-mineral complex in serum assayed to determine calcification risk
  
• Compositions and methods for the prevention and treatment of cardiovascular diseases
  
• Diagnostic assay for human matrix Gla-protein and its use as a biomarker
  
• Osf2/Cbfa1 nucleic acids and methods of use therefor
  
• Crystallization of IGF-1
  
• Activatable probes and methods for in vivo gene detection
  
• Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
  
• Insulin-like growth factor agonist molecules
  
• IGF-I point variants
  
• IGF-I variants
  
• Method of spray freeze drying proteins for pharmaceutical administration
  
• Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
  
• Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases
  
• Cyclohexyl compounds as CCR5 antagonists
  
• Substituted biphenyl GPR40 modulators
  
• Methods and compositions for vitamin K epoxide reductase
  
• Fetuin-MGP-mineral complex in serum assayed to determine calcification risk
  
• Antibodies to a chemokine expressed in inflamed adenoid
  
• Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
  
• Substituted pyrazoles, compositions containing such compounds and methods of use
  
• Wound dressing for accelerating epidermal regeneration
  
• Methods of modulating cold sensory perception
  
• Fc.gamma.RIIa transgenic animal model for autoimmune disease